TickerFactsScreenerDevelopers

BIOCRYST PHARMACEUTICALS INC (BCRX) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2009: $4.54M2010: $86.0K2016: $2.30M2017: $1.14M2019: $3.73M2020: $1.55M2021: $7.23M2022: $6.41M2023: $4.48M2024: $12.27M2025: $19.07M$19.07M
2009Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$19.07M+55.5%
2024$12.27M+173.8%
2023$4.48M-30.1%
2022$6.41M-11.4%
2021$7.23M+366.4%
2020$1.55M-58.4%
2019$3.73M—
2017$1.14M-50.3%
2016$2.30M—
2010$86.0K-98.1%
2009$4.54M—